Shares of Agios Pharmaceuticals surged nearly 15% in premarket trading on Wednesday after the US Food and Drug Administration approved an expanded use of its drug mitapivat, strengthening investor optimism around the company’s growth prospects.The approval allows mitapivat to be used to treat anemia in patients with both non-transfusion-dependent and…
Nvidia stock (NASDAQ: NVDA) tumbled nearly 1% on Wednesday after reports surfaced that the AI chipmaker has paused testing…
Gold prices took a breather on Christmas Eve after rising above the psychologically-crucial level of $4,500 per ounce. Silver prices…
European markets drifted into the Christmas break as thin trading left the FTSE slightly lower, even as the index…
Wall Street closed higher for a fifth consecutive session on Wednesday, with the Dow Jones Industrial Average gaining approximately…
Markets tiptoed into Christmas with records on thin ice. US equities notched fresh highs in a shortened session, Japan…
Tesla’s profit mix is shifting toward its energy business, a trend one Seeking Alpha analysis argues supports a prudent…
Apple CEO Tim Cook sent a powerful signal Wednesday when he spent nearly $3 million to nearly double his…
Nvidia dropped $20 billion to acquire Groq, an artificial intelligence startup that’s been eating into Nvidia’s dominance in a…